{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T12:05:38Z","timestamp":1749211538465},"reference-count":8,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2006,6,30]],"date-time":"2006-06-30T00:00:00Z","timestamp":1151625600000},"content-version":"vor","delay-in-days":3436,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pacing Clinical Electrophis"],"published-print":{"date-parts":[[1997,2]]},"abstract":"<jats:p>The aim of the study was to evaluate chronic atrial pacing threshold increase after oral propafenone therapy. Fifty patients affected by advanced AV block and sick sinus syndrome were studied at least 6 months after pacemaker implantation, before and after oral propafenone therapy (450\u2013900 mg\/day based on body weight). The patients were subdivided into three groups as to the type of electrode implanted, all three unipolar: group I (20 patients) Medtronic CapSure 4003, group II (13 patients) Medtronic Target Tip 4011, group III (17 patients) Medtronic 4057 screw\u2010in leads. In all cases, Medtronic unipolar pacemakers were implanted with the same noninvasive autothreshold measurement method. Propafenone and 5\u2010OH\u2010propafenone blood levels were measured 3\u20135 hours after drug administration. The pacing autothreshold was measured at 0.8, 1.6, and 2.5 V by reducing the pulse width. After propafenone. groups II and III showed a statistically significant threshold rise (P ranging from &lt; 0.01 to &lt;0.05), whereas no significant difference was found in group I. Propafenone and 5\u2010OH\u2010propafenone blood levels did not show any significant difference among the three groups. Strength\u2010durution curves were drawn for the three groups before und after propafenone: at baseline the curves shifted to the left with the steep part above the knee, clearly favoring CapSure over the other two groups. After propafenone, the curves shifted to the right, with the flat part progressively more evident in groups II and III. In the atrial chamber, steroid\u2010eluting leads prevented threshold increase after propafenone therapy, in contrast with a significant threshold rise with conventional porous and screw\u2010in leads.<\/jats:p>","DOI":"10.1111\/j.1540-8159.1997.tb06167.x","type":"journal-article","created":{"date-parts":[[2006,7,2]],"date-time":"2006-07-02T17:43:06Z","timestamp":1151862186000},"page":"240-244","source":"Crossref","is-referenced-by-count":6,"title":["Steroid\u2010Eluting Electrodes Prevent Chronic Pacing Threshold Rise in the Atrial Chamher After Oral Propafenone Administration"],"prefix":"10.1111","volume":"20","author":[{"given":"DANIELE","family":"CORNACCHIA","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MAURO","family":"FABBRI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALEARDO","family":"MARESTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANDREA","family":"PUGLISI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RENATO","family":"RICCI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PAOLO","family":"AZZOLINI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PASQUALE","family":"NIGRO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FRANCESCO","family":"SORRENTINO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PIERO","family":"SESTU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ANTONIO","family":"SANNA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GIOVANNI QUINTO","family":"VILLANI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GIOVANNI","family":"DIECI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ALESSANDRO","family":"CAPUCCI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FRANCESCO","family":"DE SETA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,30]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"233","article-title":"Effects of propafenone on atrial and ventricular pacing threshold in humans. Preliminary study","volume":"6","author":"Nigro P","year":"1988","journal-title":"Cardistimolazione"},{"key":"e_1_2_1_3_2","first-page":"405","article-title":"Variations in ventricular pacing threshold and paced QRS width in patients treated with flecainide and propafenone","volume":"1","author":"Nigro P","year":"1990","journal-title":"New Trends Arrhyth"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1992.tb03058.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(84)90499-5"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1983.tb04410.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1993.tb02334.x"},{"key":"e_1_2_1_8_2","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1540-8159.1992.tb02905.x","article-title":"The electrode\u2010tissue interface: The revolutionary role of steroid elution","volume":"15","author":"Mond H","year":"1992","journal-title":"PACE"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1540-8159.1988.tb04543.x"}],"container-title":["Pacing and Clinical Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1540-8159.1997.tb06167.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1540-8159.1997.tb06167.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,27]],"date-time":"2023-10-27T15:20:54Z","timestamp":1698420054000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1540-8159.1997.tb06167.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,2]]}},"alternative-id":["10.1111\/j.1540-8159.1997.tb06167.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1540-8159.1997.tb06167.x","archive":["Portico"],"relation":{},"ISSN":["0147-8389","1540-8159"],"issn-type":[{"value":"0147-8389","type":"print"},{"value":"1540-8159","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,2]]}}}